Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

390 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET

NCT04954820

Conditions: Disease Attributes, Disease Progression, Intestinal Well Differentiated Endocrine Tumor, +9 more
Locations: Institut de Cancérologie de l'Ouest Site d'Angers Angers, France

Institut Bergonié Bordeaux, France

CHRU Morvan Brest, France

Hospices civils de LYON - GHE Bron, France

View all 28 locations

View Trial Details

Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT06607692

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
Locations: HM Monteprincipe Boadilla del Monte, Madrid, Spain

View Trial Details

Recruiting

Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation

NCT06430021

Conditions: MEN1 Mutation, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Chu Dijon Bourgogne Dijon, France

View Trial Details

Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

NCT05636618

Conditions: Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
Locations: Mayo Clinic Jacksonville, Florida, United States

Biogenix Molecular Miami, Florida, United States

The University of Chicago Chicago, Illinois, United States

University of Iowa Iowa City, Iowa, United States

View all 19 locations

View Trial Details

Recruiting

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN

NCT06735560

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
Locations: CHU de Nantes Nantes, France

AP-HP - Site de Beaujon Paris, France

View Trial Details

Recruiting

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

NCT05918302

Conditions: Hemic and Lymphatic Diseases, Lung Neuroendocrine Neoplasm, Lymphatic Diseases, +9 more
Locations: Antwerp University Hospital (UZA) Edegem, Belgium

UCL Saint-Luc Brussels, Belgium

CHU Liège Liège, Belgium

Hospital Center University Dijon Bourgogne (CHU Bourgogne) Dijon, France

View all 27 locations

View Trial Details

Recruiting

68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

NCT04888481

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Recruiting

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

NCT06889493

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

NCT04074135

Conditions: Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +30 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

NCT02174549

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +18 more
Locations: Stanford University Palo Alto, California, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details